2 results
Approved WMOCompleted
The objective is to study the effect of beta-agonist and beta-antagonist treatment on human bone remodeling.
Approved WMOCompleted
Primary endpoint:- Successful desensitization for Mesalazine in ulcerative colitis patients with a presumed history of intolerance for Mesalazine. Secondary endpoint:- To investigate if a presumed intolerance for Mesalazine may be reproducible in a…